Latest filing published 02 Jul 2019 for ZEVRA THERAPEUTICS, INC..
Insider track record
No signal scores available.
Joseph Saluri: trading record in brief
Joseph Saluri discloses dealings in 2 companies, chiefly Lumos Pharma, Inc. and Zevra Therapeutics, Inc. Between 16 November 2011 and 30 June 2019, the trades on record add up to 12 filings.
Every open-market trade on record is a sale: 2 sales worth €365k. Outside the open market, there are 5 share grants and 3 option exercises.
The latest filing, published on 2 July 2019, reports a share grant in Zevra Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joseph Saluri
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,857 shares0Common StockSEC:0001437749-19-013392:0
- 8,487 shares0Common StockSEC:0001437749-19-009882:0
- 2,500 shares@ US$13.30Common StockSEC:0001126234-15-000124:0
- 2,500 shares@ US$3.07Common StockSEC:0001126234-15-000124:1
- 5,000 shares@ US$50.42Common StockSEC:0001126234-15-000124:2
- 1,962 shares0Common StockSEC:0001126234-15-000086:0
- 4,555 sharesCommon StockSEC:0001209191-15-035359:0
- 2,944 shares0Common StockSEC:0001126234-14-000104:0
- 4,761 shares@ US$3.07Common StockSEC:0001126234-14-000064:0
- 4,761 shares@ US$38.80Common StockSEC:0001126234-14-000064:1
- 3,000 shares0Common StockSEC:0001126234-14-000019:0
- 8,142 sharesCommon StockSEC:0001104659-11-065231:0
12 of 12 declarations